SCHEMBL5785783

SCHEMBL5785783

NCC(N)c1nc(-c2ccc(F)cc2F)c2ccccc2n1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 6/20 0.45
▸ ACHE P22303 1/20 0.41
▸ ADORA1 P30542 3/20 0.40
▸ SCN9A Q15858 2/20 0.40
▸ GRM2 Q14416 4/20 0.37
▸ MAPK14 Q16539 2/20 0.36
▸ MAPK13 O15264 1/20 0.36
▸ MAPK12 P53778 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ MAPK11 Q15759 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ CYP1A1 P04798 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP1B1 Q16678 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5801598 0.76 ADORA2A (0.54) ADORA2ASCN9AGLA
SCHEMBL6336337 0.76 SCN9A (0.48) ADORA2AACHEADORA1SCN9AMAPK14
SCHEMBL5788698 0.76 SLC6A2 (0.44) ADORA2AACHECYP2D6SLC6A2SLC6A4
SCHEMBL5787957 0.75 ADORA2A (0.48) ADORA2AACHEADORA1GRM2MAPK14
Hydrochloric Acid SCHEMBL5805884 0.75 ADORA2A (0.53) ADORA2ASCN9AGLA
SCHEMBL6328906 0.74 SCN9A (0.47) ADORA2AADORA1SCN9AGLA
SCHEMBL6329602 0.71 SCN9A (0.47) ADORA2ASCN9AGLA
SCHEMBL4753567 0.69 MAPT (0.41) ADORA2AACHEADORA1GRM2GLA
SCHEMBL5813840 0.69 BPTF (0.47) ADORA2ASCN9A
SCHEMBL4090714 0.69 MAPT (0.42) ACHEGRM2CYP3A4CYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685115-A1 NOVEL NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS Warner-Lambert Company LLC (US) 2006-08-02 — — EP claimed
WO-2005042501-A1 NOVEL NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY LLC (US) 2005-05-12 — — WO claimed
Send feedback